Feedback / Questions
sifalimumab (MDX-1103) - AstraZeneca
AstraZeneca: Q1 2014 Results
(AstraZeneca)
-
Apr 25, 2014 -
Anticipated top-line data from P2b trial for systemic lupus erythematosus in Q3 2014
Anticipated P2 data
•
Immunology • Lupus
http://www.astrazeneca.com/cs/Satellite?blobcol=urldata&blobheader=application%2Fpdf&blobheadername1=Content-Disposition&blobheadername2=MDT-Type&blobheadervalue1=inline%3B+filename%3DDownload-presentation.pdf&blobheadervalue2=abinary%3B+charset%3DUTF-8&blobkey=id&blobtable=MungoBlobs&blobwhere=1285670377871&ssbinary=true
Apr 25, 2014
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
.